[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1193407A1 - Pyrrolidine-3-ylacetic acid derivative - Google Patents

Pyrrolidine-3-ylacetic acid derivative Download PDF

Info

Publication number
HK1193407A1
HK1193407A1 HK14106800.1A HK14106800A HK1193407A1 HK 1193407 A1 HK1193407 A1 HK 1193407A1 HK 14106800 A HK14106800 A HK 14106800A HK 1193407 A1 HK1193407 A1 HK 1193407A1
Authority
HK
Hong Kong
Prior art keywords
methyl
carbamoyl
methylpyrrolidin
mmol
piperidin
Prior art date
Application number
HK14106800.1A
Other languages
English (en)
Chinese (zh)
Other versions
HK1193407B (en
Inventor
吉田郎
吉田一郎
岡部忠志
冈部忠志
松本泰信
渡邊信久
渡边信久
大橋芳章
大桥芳章
鬼澤裕二
鬼泽裕二
原田均
Original Assignee
衛材 管理有限公司
卫材R&D管理有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 衛材 管理有限公司, 卫材R&D管理有限公司 filed Critical 衛材 管理有限公司
Publication of HK1193407A1 publication Critical patent/HK1193407A1/xx
Publication of HK1193407B publication Critical patent/HK1193407B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
HK14106800.1A 2011-09-13 2012-09-11 Pyrrolidine-3-ylacetic acid derivative HK1193407B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011-199482 2011-09-13
JP2011199482 2011-09-13
PCT/JP2012/073171 WO2013039057A1 (ja) 2011-09-13 2012-09-11 ピロリジン-3-イル酢酸誘導体

Publications (2)

Publication Number Publication Date
HK1193407A1 true HK1193407A1 (en) 2014-09-19
HK1193407B HK1193407B (en) 2016-02-19

Family

ID=

Also Published As

Publication number Publication date
ES2564732T3 (es) 2016-03-28
PE20141353A1 (es) 2014-09-26
JP5829689B2 (ja) 2015-12-09
MX358494B (es) 2018-08-23
RU2615135C2 (ru) 2017-04-04
TWI543975B (zh) 2016-08-01
RU2014107536A (ru) 2015-10-20
PH12014500212A1 (en) 2014-03-03
CL2014000484A1 (es) 2014-08-22
KR101963922B1 (ko) 2019-03-29
SI2757103T1 (sl) 2016-04-29
RS54582B1 (en) 2016-08-31
CY1117460T1 (el) 2017-04-26
AU2012309556B2 (en) 2016-09-15
PL2757103T3 (pl) 2016-06-30
CA2844617A1 (en) 2013-03-21
HUE026824T2 (en) 2016-07-28
BR112014004267B1 (pt) 2021-11-16
CN103764648A (zh) 2014-04-30
ZA201400918B (en) 2015-07-29
DK2757103T3 (en) 2016-03-07
WO2013039057A1 (ja) 2013-03-21
CA2844617C (en) 2019-03-05
PT2757103E (pt) 2016-03-31
MX2014002210A (es) 2014-04-30
TW201311667A (zh) 2013-03-16
AU2012309556A1 (en) 2014-02-27
SG11201400163WA (en) 2014-06-27
IL230804A0 (en) 2014-03-31
MY169869A (en) 2019-05-27
BR112014004267A2 (pt) 2017-03-21
KR20140060286A (ko) 2014-05-19
JPWO2013039057A1 (ja) 2015-03-26
IL230804A (en) 2016-02-29
EP2757103A1 (en) 2014-07-23
HRP20160166T1 (hr) 2016-03-11
AR087788A1 (es) 2014-04-16
UA112873C2 (uk) 2016-11-10
ME02383B (me) 2016-06-20
NZ620469A (en) 2015-06-26
JO3082B1 (ar) 2017-03-15
EP2757103B1 (en) 2016-01-06
SMT201600071B (it) 2016-04-29
EP2757103A4 (en) 2015-02-18
CN103764648B (zh) 2015-07-01

Similar Documents

Publication Publication Date Title
EP2431037B1 (en) (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
US10975057B2 (en) 6-aminopyridin-3-yl pyrazoles as modulators of RORgT
JP6998204B2 (ja) Rorγtのモジュレーターとしてのトリフルオロメチルアルコール
EA029774B1 (ru) Соединения
JP2024501641A (ja) 置換大環状化合物及び関連する治療方法
US11345666B2 (en) Phenyl and pyridinyl substituted imidazoles as modulators of RORγT
JP7071400B6 (ja) 免疫プロテアソーム阻害剤
EP2757103B1 (en) Pyrrolidine-3-ylacetic acid derivative
US20240383920A1 (en) Synthesis of ras inhibitors
US8476301B2 (en) Pyrrolidin-3-ylacetic acid derivative
HK1193407B (en) Pyrrolidine-3-ylacetic acid derivative
KR20150129698A (ko) 피롤리딘-3-일 아세트산 유도체의 염 및 그의 결정
HK1198034A (en) Pyrrolidine-3-ylacetic acid derivative
WO2014142086A1 (ja) ピロリジン-3-イル酢酸誘導体およびピペリジン-3-イル酢酸誘導体
KR20190110549A (ko) 페닐디플루오로메틸 치환 프롤린아미드 화합물
NZ620469B2 (en) Pyrrolidine-3-ylacetic acid derivative

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230909